KALA BIO Soars 10.65% on Bullish Analyst Coverage

On September 8, 2025, KALA BIO's stock surged by 10.65% in pre-market trading, reflecting a significant boost in investor confidence and market sentiment.

KALA BIO, Inc. has seen a substantial increase in its market capitalization, rewarding retail investors who have significant stakes in the company. This surge is indicative of the growing optimism surrounding the company's future prospects.

Mizuho has initiated coverage on KALA BIO with an "Outperform" rating and a price target of $30, further bolstering investor confidence in the company's growth potential.

Lifesci Capital has issued Q3 2025 earnings estimates for KALA BIO, highlighting the company's financial performance and growth trajectory. The stock has experienced a remarkable 400% increase over the past month, driven by positive market sentiment and analysts projecting growth potential.